阿斯利康AstraZeneca plc (AZN) 2020年年度报告「LSE」.pdf

1、What science can doAstraZeneca Annual Report and Form 20-F Information 2020We are a global,science-led,patient-focused pharmaceutical company.We are tireless in seeking to realise the potential of.what science can do.In this Annual Report we report on the progress we made in 2020 in pushing the boun

2、daries of science to deliver life-changing medicines.Our Strategic ReportHow our therapy areas and business performed in delivering our strategic priorities in 2020,including our response to the COVID-19 pandemic.See our Strategic Report from page 2.Our Corporate Governance ReportHow we are managed

3、and take decisions,including our report on Directors remuneration.See our Corporate Governance Report from page 101.Our Financial Statements and Additional InformationDetailed information on our finances,our marketed medicines and medicines in development,as well as information for shareholders.See

4、our Financial Statements from page 169 and Additional Information from page 245.Use of terms:In this Annual Report,unless the context otherwise requires,AstraZeneca,the Group,we,us and our refer to AstraZeneca PLC and its consolidated entities.Front cover image:Clinical innovation Digital technologi

5、es are creating never-seen-before opportunities to capture real-time data from patients.AstraZeneca is growing its digital capabilities across R&D to explore how we can better inform our clinical trials and help patients prevent,manage or treat their disease.Inside front cover image:Data science&AI

6、are transforming drug discovery and development.WelcomeCorporate GovernanceChairmans Introduction 102Corporate Governance Overview 103Board of Directors 104Senior Executive Team 106Corporate Governance Report 108Science Committee Report 119Nomination and Governance Committee Report 120Audit Committe